Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI Trial

Published:2012-06 Issue:6 Volume:20 Page:1280-1286
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Powell Richard J,Marston William A,Berceli Scott A,Guzman Raul,Henry Timothy D,Longcore Amy T,Stern Theresa P,Watling Sharon,Bartel Ronnda L

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference16 articles.

1. Ethnic-specific prevalence of peripheral arterial disease in the United States;Allison;Am J Prev Med,2007

2. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999–2004;Ostchega;J Am Geriatr Soc,2007

3. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II);Norgren;Eur J Vasc Endovasc Surg,2007

4. Contemporary management of infrapopliteal peripheral arterial disease;Falluji;Angiology,2011

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Therapy for Wound Healing in Ischemic Limbs;Advances in Surgery;2024-09

2. PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial;British Journal of Surgery;2024-01-31

3. Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?;Molecular Diagnosis & Therapy;2023-09-22

4. Transplantation of Mesenchymal Stem Cells as a New Approach for Cardiovascular Diseases: From Bench to Bedside: A Perspective;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-09-07

5. A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells;Stem Cell Research & Therapy;2023-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3